The discussion emphasizes the importance of flexible allocation strategies, questioning traditional percentage limits in favor of a more holistic view of portfolio management. Confidence in both the team and governance allows for strategic decisions, such as focusing on specific sectors like biotech, while avoiding the pitfalls of over-diversification. The approach prioritizes partnerships with strong managers to optimize overall performance rather than adhering strictly to arbitrary allocations.
